Drug Design Methodologies
St Louis
About Drug Design Methodologies
Drug Design Methodologies develops novel computational software for structure-based drug design. The software chemically optimizes and accurately measures drug-target binding. By identifying and focusing resources upon promising candidates and eliminating problematic compounds that could exhibit off-target effects, Drug Design Methodologies accelerates and de-risks drug development pipelines in pharmaceutical and biotechnology industries while lowering costs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $50.0K
- Last round: Grant (Nov 2017)
- Website: newdrugdesign.weebly.com
Industries & Categories
Biotechnology, Pharmaceutical, Software
Social Profiles
Canonical: https://fsome.com/organization/drug-design-methodologies-2222131 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.